Correlation Between Israel Discount and XTL Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel Discount and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel Discount and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel Discount Bank and XTL Biopharmaceuticals, you can compare the effects of market volatilities on Israel Discount and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel Discount with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel Discount and XTL Biopharmaceutica.

Diversification Opportunities for Israel Discount and XTL Biopharmaceutica

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Israel and XTL is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Israel Discount Bank and XTL Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Israel Discount is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel Discount Bank are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Israel Discount i.e., Israel Discount and XTL Biopharmaceutica go up and down completely randomly.

Pair Corralation between Israel Discount and XTL Biopharmaceutica

Assuming the 90 days trading horizon Israel Discount Bank is expected to generate 0.43 times more return on investment than XTL Biopharmaceutica. However, Israel Discount Bank is 2.3 times less risky than XTL Biopharmaceutica. It trades about 0.09 of its potential returns per unit of risk. XTL Biopharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest  240,461  in Israel Discount Bank on September 26, 2024 and sell it today you would earn a total of  6,239  from holding Israel Discount Bank or generate 2.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Israel Discount Bank  vs.  XTL Biopharmaceuticals

 Performance 
       Timeline  
Israel Discount Bank 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Israel Discount Bank are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Israel Discount sustained solid returns over the last few months and may actually be approaching a breakup point.
XTL Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTL Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Israel Discount and XTL Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel Discount and XTL Biopharmaceutica

The main advantage of trading using opposite Israel Discount and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel Discount position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.
The idea behind Israel Discount Bank and XTL Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data